Antoine Hollebecque
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Immune-related adverse events with immune checkpoint blockade: a comprehensive review(2016)2,094 cited
- → Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations(2015)1,714 cited
- → Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study(2020)1,533 cited
- → Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2015)1,308 cited
- → A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study(2018)1,203 cited
- → Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1(2016)1,185 cited
- → High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial(2017)760 cited
- → The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids(2007)718 cited
- → Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial(2020)576 cited
- → Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E-Mutant Colorectal Cancer(2018)574 cited